Aberrant activation of intracellular signaling involving the MEK pathway contributes to thyroid tumorigenesis since MEK inhibition favors differentiation of radioiodine-refractory DTCs by restoring NIS expression [86,95,96]. Here, MAP2K7 is linked to thyroid gland disorder.